1. Efficacy of cetuximab-containing regimens in the treatment of recurrent/metastatic head and neck cancer after progression to immune checkpoint inhibitors. Issue 6 (10th June 2022) Authors: Lai, Cheng-Lun; Chen, Tien-Hua; Chang, Peter Mu-Hsin; Tai, Shyh-Kuan; Chu, Pen-Yuan; Yang, Muh-Hwa Journal: Journal of the Chinese Medical Association Issue: Volume 85:Issue 6(2022) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗